Prashant Shrikrishna Karkare

Executive

Goldline Pharmaceutical

Insider activity · 24 months1 buy0 sales

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 1 buy · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 14 Aug 2026 for Goldline Pharmaceutical. Read the official filing

Filing timeline

BuySale

Prashant Shrikrishna Karkare

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Prashant Shrikrishna Karkare: trading record in brief

Prashant Shrikrishna Karkare is a declared insider of Goldline Pharmaceutical, with filings sourced from SEBI (PIT + SAST). The record holds 2 filings, for trades running from 29 July 2026 to 14 August 2026.

On the market, this insider has only ever bought: 2 purchases. The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The newest entry dates from 14 August 2026: an open-market purchase, in Goldline Pharmaceutical. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.